
Serum B12, homocysteine levels, and their effect on peripheral neuropathy in Parkinson's disease: Indian cohort
Author(s) -
Neeharika L Mathukumalli,
Mridula R Kandadai,
Jabeen A Shaik,
Meena A Kanikannan,
Rupam Borgohain
Publication year - 2020
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_478_18
Subject(s) - medicine , hyperhomocysteinemia , homocysteine , vitamin b12 , gastroenterology , parkinson's disease , peripheral neuropathy , cobalamin , population , cohort , disease , endocrinology , diabetes mellitus , environmental health
Cobalamin deficiency, either due to dietary inadequacy or increased consumption attributable to levodopa-mediated metabolic disturbance, and resultant hyperhomocysteinemia may contribute to peripheral neuropathy (PN) in Parkinson's disease (PD).